Remicade is an injectable medication used to treat certain forms of arthritis, including rheumatoid arthritis and psoriatic arthritis. It is a monoclonal antibody and works by inhibiting a protein in the immune system that contributes to inflammation.

Rheumatoid arthritis (RA) is an autoimmune disorder that causes stiffness and pain in the joints, along with swelling and destruction of joint tissue. Psoriatic arthritis (PsA) is a form of arthritis associated with psoriasis and causes joint pain, swelling, and destruction of joint tissue.

The active ingredient in Remicade is infliximab, a monoclonal antibody that binds to tumor necrosis factor (TNF). TNF plays a vital role in the body’s inflammation response, but it’s overproduction can trigger and worsen RA and PsA. By targeting and neutralizing TNF, Remicade works to reduce inflammation and joint destruction in patients with RA and PsA.

Remicade is typically administered intravenously as an infusion, but it can also be given as an injection into the skin or muscle. Infusions are typically administered at intervals of 2-8 weeks based on the patient’s response to treatment and other factors. Injections can be self-administered at home or administered in the clinic at shorter intervals, such as once a month.

The most common side effects of Remicade include upper respiratory infection, fatigue, abdominal pain, headache, and nausea. Serious side effects can include lupus-like syndrome, heart failure, and a serious neurological disorder called progressive multifocal leukoencephalopathy (PML).

Remicade is an effective treatment for RA and PsA, but it must be used with caution. Patients taking Remicade must be monitored carefully for side effects and other complications.

Check out some of the links above from our sponsors.